C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
OWLT Equity

OWLT

OTCMKTS · OWLT

$4.41
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 1/5
48/100 composite
Fundamentals62
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Owlet carries a Neutral rating with low conviction at 1/5, reflecting a 48.5 composite that lacks sufficient breadth for a directional call. Fundamentals lead the framework at 62.0, supported primarily by an 84.8 gross-margin subscore, a 63.2 cash-runway subscore, and a 58.1 operating-margin subscore. Regulatory contributes 49.0, where an 80.0 enforcement subscore offsets a weak 25.0 cadence reading and a 50.0 jurisdiction score. Market contributes 40.0 because no quote was available from institutional pricing feeds, while editorial contributes 30.0 amid no identified newsroom or brief activity in CIN newsroom coverage. The pillar mix supports the Neutral band rather than Overweight, as the strongest operating attributes remain counterbalanced by limited regulatory cadence, absent market pricing confirmation, and muted editorial visibility.

Licensed fundamentals data show year-over-year revenue growth of 6.4%, providing positive but modest top-line momentum. Gross margin stands near 50.9%, the clearest operating strength and the principal reason fundamentals rank above every other pillar. That strength has not translated into profitability: operating margin remains negative at 24.45%, net income is a loss of roughly $46.0 million, and EBITDA is negative by approximately $10.9 million. The 6.14% cash-burn ratio and 63.2 cash-runway subscore provide some fundamental support, but the stated financial condition remains stretched and the bottom-line loss preserves material funding and execution pressure. Primary regulatory filings show no latest filing date, no identified events during either the 90-day or 180-day periods, and no enforcement hits, producing a clean enforcement signal but a thin filing-cadence record.

The forward catalyst rests squarely on the fundamentals pillar, particularly conversion of the near-51% gross margin into improved operating leverage. Faster revenue growth against that margin structure could narrow the operating and EBITDA losses, strengthen the 62.0 fundamentals score, and create a credible path toward a higher composite rating. Regulatory stability offers secondary support, but sparse filing activity, unavailable pricing evidence, and absent CIN newsroom coverage prevent those pillars from driving the thesis. The single most important signal to watch is sustained improvement in operating margin while gross margin remains near its current level.

Scored: 2026-10-14Valid through: 2026-11-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
2940 WEST MAPLE LOOP DRIVE, SUITE 203, LEHI, UT, 84048
Phone
8443345330
CEO
Kurt Workman
CFO
Amanda Twede Crawford
Auditor
Salt Lake City
SEC CIK
1816708
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$177.0M
Enterprise value
$173.2M
Price to book
7.69
Price to sales
1.65
EV / EBITDA
-0.61
Revenue (TTM)
$107.1M
Gross profit (TTM)
$54.4M
EBITDA
$-10.9M
Operating margin
-24.4%
Profit margin
-43.0%
Rev growth YoY
6.4%
Return on equity
-526.2%
Return on assets
-10.0%
EPS (TTM)
$-2.57
EPS est. current year
$0.13
Wall St. target price
$13.00
Shares outstanding
29.1M
Insider ownership
10.5%
Institutional ownership
74.5%
Beta
1.84
Full-time employees
108
GICS sector
Healthcare
GICS industry
Medical Devices
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for OWLT (OWLT)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for OWLT (OWLT), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for OWLT are maintained by Cannabis Investor News and refreshed throughout the trading day.